215 related articles for article (PubMed ID: 32699137)
1. CHD4 Promotes Breast Cancer Progression as a Coactivator of Hypoxia-Inducible Factors.
Wang Y; Chen Y; Bao L; Zhang B; Wang JE; Kumar A; Xing C; Wang Y; Luo W
Cancer Res; 2020 Sep; 80(18):3880-3891. PubMed ID: 32699137
[TBL] [Abstract][Full Text] [Related]
2. STAT3 or USF2 contributes to HIF target gene specificity.
Pawlus MR; Wang L; Murakami A; Dai G; Hu CJ
PLoS One; 2013; 8(8):e72358. PubMed ID: 23991099
[TBL] [Abstract][Full Text] [Related]
3. ZMYND8 acetylation mediates HIF-dependent breast cancer progression and metastasis.
Chen Y; Zhang B; Bao L; Jin L; Yang M; Peng Y; Kumar A; Wang JE; Wang C; Zou X; Xing C; Wang Y; Luo W
J Clin Invest; 2018 May; 128(5):1937-1955. PubMed ID: 29629903
[TBL] [Abstract][Full Text] [Related]
4. BRG1 and BRM chromatin-remodeling complexes regulate the hypoxia response by acting as coactivators for a subset of hypoxia-inducible transcription factor target genes.
Sena JA; Wang L; Hu CJ
Mol Cell Biol; 2013 Oct; 33(19):3849-63. PubMed ID: 23897427
[TBL] [Abstract][Full Text] [Related]
5. Breast tumor kinase (Brk/PTK6) is a mediator of hypoxia-associated breast cancer progression.
Regan Anderson TM; Peacock DL; Daniel AR; Hubbard GK; Lofgren KA; Girard BJ; Schörg A; Hoogewijs D; Wenger RH; Seagroves TN; Lange CA
Cancer Res; 2013 Sep; 73(18):5810-20. PubMed ID: 23928995
[TBL] [Abstract][Full Text] [Related]
6. Estrogen-dependent downregulation of hypoxia-inducible factor (HIF)-2α in invasive breast cancer cells.
Fuady JH; Gutsche K; Santambrogio S; Varga Z; Hoogewijs D; Wenger RH
Oncotarget; 2016 May; 7(21):31153-65. PubMed ID: 27105516
[TBL] [Abstract][Full Text] [Related]
7. HER2 regulates HIF-2α and drives an increased hypoxic response in breast cancer.
Jarman EJ; Ward C; Turnbull AK; Martinez-Perez C; Meehan J; Xintaropoulou C; Sims AH; Langdon SP
Breast Cancer Res; 2019 Jan; 21(1):10. PubMed ID: 30670058
[TBL] [Abstract][Full Text] [Related]
8. STAT3 and HIF1α cooperatively activate HIF1 target genes in MDA-MB-231 and RCC4 cells.
Pawlus MR; Wang L; Hu CJ
Oncogene; 2014 Mar; 33(13):1670-9. PubMed ID: 23604114
[TBL] [Abstract][Full Text] [Related]
9. The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha.
Hu CJ; Sataur A; Wang L; Chen H; Simon MC
Mol Biol Cell; 2007 Nov; 18(11):4528-42. PubMed ID: 17804822
[TBL] [Abstract][Full Text] [Related]
10. PRDX2 and PRDX4 are negative regulators of hypoxia-inducible factors under conditions of prolonged hypoxia.
Luo W; Chen I; Chen Y; Alkam D; Wang Y; Semenza GL
Oncotarget; 2016 Feb; 7(6):6379-97. PubMed ID: 26837221
[TBL] [Abstract][Full Text] [Related]
11. ITGA6 is directly regulated by hypoxia-inducible factors and enriches for cancer stem cell activity and invasion in metastatic breast cancer models.
Brooks DL; Schwab LP; Krutilina R; Parke DN; Sethuraman A; Hoogewijs D; Schörg A; Gotwald L; Fan M; Wenger RH; Seagroves TN
Mol Cancer; 2016 Mar; 15():26. PubMed ID: 27001172
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP promotes breast cancer invasion and epithelial-mesenchymal transition via hypoxia-inducible factor 2α signaling.
Yang H; Geng YH; Wang P; Zhou YT; Yang H; Huo YF; Zhang HQ; Li Y; He HY; Tian XX; Fang WG
Cancer Sci; 2019 Aug; 110(8):2456-2470. PubMed ID: 31148343
[TBL] [Abstract][Full Text] [Related]
13. Enhanceosomes as integrators of hypoxia inducible factor (HIF) and other transcription factors in the hypoxic transcriptional response.
Pawlus MR; Hu CJ
Cell Signal; 2013 Sep; 25(9):1895-903. PubMed ID: 23707522
[TBL] [Abstract][Full Text] [Related]
14. HIF-2α promotes conversion to a stem cell phenotype and induces chemoresistance in breast cancer cells by activating Wnt and Notch pathways.
Yan Y; Liu F; Han L; Zhao L; Chen J; Olopade OI; He M; Wei M
J Exp Clin Cancer Res; 2018 Oct; 37(1):256. PubMed ID: 30340507
[TBL] [Abstract][Full Text] [Related]
15. Multiple receptor tyrosine kinases regulate HIF-1alpha and HIF-2alpha in normoxia and hypoxia in neuroblastoma: implications for antiangiogenic mechanisms of multikinase inhibitors.
Nilsson MB; Zage PE; Zeng L; Xu L; Cascone T; Wu HK; Saigal B; Zweidler-McKay PA; Heymach JV
Oncogene; 2010 May; 29(20):2938-49. PubMed ID: 20208561
[TBL] [Abstract][Full Text] [Related]
16. HIF isoforms have divergent effects on invasion, metastasis, metabolism and formation of lipid droplets.
Shah T; Krishnamachary B; Wildes F; Mironchik Y; Kakkad SM; Jacob D; Artemov D; Bhujwalla ZM
Oncotarget; 2015 Sep; 6(29):28104-19. PubMed ID: 26305551
[TBL] [Abstract][Full Text] [Related]
17. Increased activation of the hypoxia-inducible factor pathway in varicose veins.
Lim CS; Kiriakidis S; Paleolog EM; Davies AH
J Vasc Surg; 2012 May; 55(5):1427-39. PubMed ID: 22277691
[TBL] [Abstract][Full Text] [Related]
18. HSulf-1 modulates FGF2- and hypoxia-mediated migration and invasion of breast cancer cells.
Khurana A; Liu P; Mellone P; Lorenzon L; Vincenzi B; Datta K; Yang B; Linhardt RJ; Lingle W; Chien J; Baldi A; Shridhar V
Cancer Res; 2011 Mar; 71(6):2152-61. PubMed ID: 21266348
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha.
Fath DM; Kong X; Liang D; Lin Z; Chou A; Jiang Y; Fang J; Caro J; Sang N
J Biol Chem; 2006 May; 281(19):13612-13619. PubMed ID: 16543236
[TBL] [Abstract][Full Text] [Related]
20. Identification of the hypoxia-inducible factor 2α nuclear interactome in melanoma cells reveals master proteins involved in melanoma development.
Steunou AL; Ducoux-Petit M; Lazar I; Monsarrat B; Erard M; Muller C; Clottes E; Burlet-Schiltz O; Nieto L
Mol Cell Proteomics; 2013 Mar; 12(3):736-48. PubMed ID: 23275444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
